CytoReason Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company collects proprietary data from pharma companies and uses it to simulate human diseases tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.